- Home
- BBIO vs BBY Comparison
BBIO vs BBY Comparison
Compare BBIO & BBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BBIO | BBY |
|---|---|---|
| Founded | 2015 | 1966 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Consumer Electronics/Video Chains |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.9B | 18.2B |
| IPO Year | 2019 | 1994 |
Fundamental Metrics
Financial Performance| Metric | BBIO | BBY |
|---|---|---|
| Price | $65.53 | $90.45 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 25 | 19 |
| Target Price | ★ $86.33 | $76.28 |
| AVG Volume (30 Days) | 2.3M | ★ 3.8M |
| Earning Date | 05-12-2026 | 05-28-2026 |
| Dividend Yield | N/A | ★ 6.54% |
| EPS Growth | N/A | ★ 17.76 |
| EPS | N/A | ★ 2.79 |
| Revenue | $502,076,000.00 | ★ $41,691,000,000.00 |
| Revenue This Year | $89.45 | $1.15 |
| Revenue Next Year | $73.78 | $1.38 |
| P/E Ratio | ★ N/A | $32.62 |
| Revenue Growth | ★ 126.26 | 0.39 |
| 52 Week Low | $50.68 | $55.10 |
| 52 Week High | $93.42 | $96.53 |
Technical Indicators
Market Signals| Indicator | BBIO | BBY |
|---|---|---|
| Relative Strength Index (RSI) | 28.95 | 52.46 |
| Support Level | $63.47 | $60.97 |
| Resistance Level | $70.49 | N/A |
| Average True Range (ATR) | 2.84 | 2.91 |
| MACD | -0.40 | -0.21 |
| Stochastic Oscillator | 7.18 | 38.11 |
Price Performance
Historical ComparisonAbout BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About BBY Best Buy Co. Inc.
Best Buy Co Inc is a pure-play consumer electronics retailer in the USA. It has two reportable segments: Domestic and International. The Domestic and International segments have offerings in six revenue categories. Computing and Mobile Phones, Consumer Electronics, Appliances, Entertainment, Services, and Other. The company has approximately 1,068 stores throughout its Domestic and International segments. It also have vendor store-within-a-store concepts to allow closer vendor partnerships and a higher quality customer experience. The company generates majority of its revenue from the Domestic segment.